Hemopa and Roche promote meeting on decentralization of hemophilia care

The Hemotherapy and Hematology Center Foundation of Pará (Hemopa) hosted a lecture on Thursday (22) in partnership with Roche, a global pharmaceutical and diagnostic company. Held in the auditorium of the headquarters in Belém, the meeting reinforced the importance of decentralizing healthcare services, expanding access to treatments in more remote regions.

Professionals from the field and representatives from both institutions discussed the challenges faced in public care, especially regarding travel to the interior of the state, and highlighted the need for joint action to ensure that medications and services reach patients.

The Technical Director of the Hemopa Foundation, Larissa Francês, emphasized that the partnership strengthens the mission to decentralize care. “Roche embraced the idea of going to the interior, which is already our routine. They were able to see firsthand the difficulties we face, and this helps to seek solutions so that medication reaches those in need. Alone we cannot do it; with partnerships like this, the ones who benefit are the patients,” she stated.

Larissa also highlighted that the event was an opportunity to present the work developed by the multidisciplinary team of the Hemopa Foundation. “This lecture was a way to show what we already do here, with quality and a focus on the patient. This recognition is important for us to seek new achievements,” she added.

The president of Roche in Brazil, Lorice Scalise, praised the structure of the Hemopa Foundation and the projects presented. A Brazilian executive recognized for her experience, vision, and commitment to equity, Lorice is the first woman and the first Latin American to lead Roche Farma in Brazil, a position she has held since April 2023.

Born in Borborema, in the interior of São Paulo, she graduated in Pharmacy from the São Paulo State University (Unesp) and began her journey at Roche in 2000, working in various areas and countries, such as Switzerland, Japan, and Argentina. With over 20 years of experience, Lorice leads initiatives that expand access to innovative treatments, including laboratory automation and the integration of data from the Unified Health System (SUS).

“I was enchanted by everything. The strength of decentralizing care struck me deeply. The speech of the social worker about walking the path alongside the patient touched me profoundly. This requires empathy,” she highlighted.

She also emphasized the importance of comprehensive patient care as a differentiator. “At the Hemopa Foundation, the patient is treated as a human being, not just by the disease. The structure offers everything from social support to psychological support. It is rare to see this so well organized,” she pointed out.

Lorice also stressed that the model applied by the Hemopa Foundation can inspire other institutions in the country. “The SUS is the greatest gain of Brazilian democracy. When there is good management and willingness, it is possible to carry out incredible work. What the Hemopa Foundation does in the treatment of hemophilia can serve as an example for many other areas,” she concluded.

*Text in collaboration with Felipe Borges (intern)